Hamrick Investment Counsel’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Hold
450
– – 0.01% 121
2026
Q1
$21.7K Hold
450
– – 0.01% 196
2025
Q4
$21.8K Buy
+450
New +$22.3K 0.02% 111

Other funds holding SNY

Hamrick Investment Counsel's SNY Position: Q2 2026 in Review

Hamrick Investment Counsel held its Sanofi (SNY) position steady in Q2 2026 at 450 shares worth $19.2K. The position accounts for 0.01% of the portfolio, ranked #121.

Hamrick Investment Counsel first reported a position in SNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $21.8K in Q4 2025. 719 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Hamrick Investment Counsel held 450 shares of Sanofi worth $19.2K as of Q2 2026.
  • Hamrick Investment Counsel left its Sanofi share count unchanged in Q2 2026.
  • Sanofi made up 0.01% of Hamrick Investment Counsel's portfolio in Q2 2026, its #121 holding.
  • Hamrick Investment Counsel first reported a position in Sanofi in Q4 2025 and has held it in 3 quarters since.
  • Hamrick Investment Counsel's Sanofi position peaked at $21.8K in Q4 2025.
  • 719 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.